Presenilin 1 hemizygosity has no overt deleterious phenotypic outcomes in sheep: Potential implications for therapeutic targets in Alzheimer's disease.
Alzforum,
Mckean NE, Liu J, Rudiger SR, Kelly JM, McLaughlan C, Verma PJ, Hardy J, Gusella JF, Zetterberg H, Reid SJ, Handley RH, Lehnert…